March 2nd 2021
Neurotech expands exclusive license to include all neurological disorders
February 15th 2021
Neurotech to commence clinical study program this quarter
December 21st 2020
NTI Complete In Vitro Studies on Cannabis Strains, Clinical Trials Await
April 1st 2020
OncoSil™ receives CE Mark approval
Connect with us
Subscribe for updates on our small cap, ASX listed biotech portfolio.
Thanks for subscribing!